510(k) K213603
K213603 is an FDA 510(k) premarket notification submitted by Ge Healthcare (Tianjin) Company Limited for the device "SIGNA Artist Evo". The FDA issued a decision of Substantially Equivalent on February 11, 2022. The device falls under product code LNH (System, Nuclear Magnetic Resonance Imaging), a Class II device regulated under 21 CFR 892.1000. Ge Healthcare (Tianjin) Company Limited has at least 5 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 11, 2022
- Date Received
- November 15, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Nuclear Magnetic Resonance Imaging
- Device Class
- Class II
- Regulation Number
- 892.1000
- Review Panel
- RA
- Submission Type